Bioingenium

Bioingenium does not develop its own clinical pipeline but provides custom process development services—including strain/cell line engineering, upstream/downstream processing, analytical tool development—for recombinant protein production across bacteria (E. coli), yeast (Pichia pastoris), mammalian cells (CHO/HEK). The company serves over 150 clients globally in biopharma, animal health, diagnostics/research reagents, cosmetics active ingredients via fermentation/natural ferments innovation—and alternative protein/enzyme production for the food sector. It has grown rapidly in recent years by diversifying into new markets while maintaining strong R&D capabilities.